Cargando…
Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further
The genome of gut microbes encodes a collection of enzymes whose metabolic functions contribute to the bioavailability and bioactivity of unabsorbed (poly)phenols. Datasets from high throughput sequencing, metabolome measurements, and other omics have expanded the understanding of the different mode...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276758/ https://www.ncbi.nlm.nih.gov/pubmed/34268328 http://dx.doi.org/10.3389/fnut.2021.689456 |
_version_ | 1783721961541599232 |
---|---|
author | Rodríguez-Daza, Maria Carolina Pulido-Mateos, Elena C. Lupien-Meilleur, Joseph Guyonnet, Denis Desjardins, Yves Roy, Denis |
author_facet | Rodríguez-Daza, Maria Carolina Pulido-Mateos, Elena C. Lupien-Meilleur, Joseph Guyonnet, Denis Desjardins, Yves Roy, Denis |
author_sort | Rodríguez-Daza, Maria Carolina |
collection | PubMed |
description | The genome of gut microbes encodes a collection of enzymes whose metabolic functions contribute to the bioavailability and bioactivity of unabsorbed (poly)phenols. Datasets from high throughput sequencing, metabolome measurements, and other omics have expanded the understanding of the different modes of actions by which (poly)phenols modulate the microbiome conferring health benefits to the host. Progress have been made to identify direct prebiotic effects of (poly)phenols; albeit up to date, these compounds are not recognized as prebiotics sensu stricto. Interestingly, certain probiotics strains have an enzymatic repertoire, such as tannase, α-L-rhamnosidase, and phenolic acid reductase, involved in the transformation of different (poly)phenols into bioactive phenolic metabolites. In vivo studies have demonstrated that these (poly)phenol-transforming bacteria thrive when provided with phenolic substrates. However, other taxonomically distinct gut symbionts of which a phenolic-metabolizing activity has not been demonstrated are still significantly promoted by (poly)phenols. This is the case of Akkermansia muciniphila, a so-called antiobesity bacterium, which responds positively to (poly)phenols and may be partially responsible for the health benefits formerly attributed to these molecules. We surmise that (poly)phenols broad antimicrobial action free ecological niches occupied by competing bacteria, thereby allowing the bloom of beneficial gut bacteria. This review explores the capacity of (poly)phenols to promote beneficial gut bacteria through their direct and collaborative bacterial utilization and their inhibitory action on potential pathogenic species. We propose the term duplibiotic, to describe an unabsorbed substrate modulating the gut microbiota by both antimicrobial and prebiotic modes of action. (Poly)phenol duplibiotic effect could participate in blunting metabolic disturbance and gut dysbiosis, positioning these compounds as dietary strategies with therapeutic potential. |
format | Online Article Text |
id | pubmed-8276758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82767582021-07-14 Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further Rodríguez-Daza, Maria Carolina Pulido-Mateos, Elena C. Lupien-Meilleur, Joseph Guyonnet, Denis Desjardins, Yves Roy, Denis Front Nutr Nutrition The genome of gut microbes encodes a collection of enzymes whose metabolic functions contribute to the bioavailability and bioactivity of unabsorbed (poly)phenols. Datasets from high throughput sequencing, metabolome measurements, and other omics have expanded the understanding of the different modes of actions by which (poly)phenols modulate the microbiome conferring health benefits to the host. Progress have been made to identify direct prebiotic effects of (poly)phenols; albeit up to date, these compounds are not recognized as prebiotics sensu stricto. Interestingly, certain probiotics strains have an enzymatic repertoire, such as tannase, α-L-rhamnosidase, and phenolic acid reductase, involved in the transformation of different (poly)phenols into bioactive phenolic metabolites. In vivo studies have demonstrated that these (poly)phenol-transforming bacteria thrive when provided with phenolic substrates. However, other taxonomically distinct gut symbionts of which a phenolic-metabolizing activity has not been demonstrated are still significantly promoted by (poly)phenols. This is the case of Akkermansia muciniphila, a so-called antiobesity bacterium, which responds positively to (poly)phenols and may be partially responsible for the health benefits formerly attributed to these molecules. We surmise that (poly)phenols broad antimicrobial action free ecological niches occupied by competing bacteria, thereby allowing the bloom of beneficial gut bacteria. This review explores the capacity of (poly)phenols to promote beneficial gut bacteria through their direct and collaborative bacterial utilization and their inhibitory action on potential pathogenic species. We propose the term duplibiotic, to describe an unabsorbed substrate modulating the gut microbiota by both antimicrobial and prebiotic modes of action. (Poly)phenol duplibiotic effect could participate in blunting metabolic disturbance and gut dysbiosis, positioning these compounds as dietary strategies with therapeutic potential. Frontiers Media S.A. 2021-06-28 /pmc/articles/PMC8276758/ /pubmed/34268328 http://dx.doi.org/10.3389/fnut.2021.689456 Text en Copyright © 2021 Rodríguez-Daza, Pulido-Mateos, Lupien-Meilleur, Guyonnet, Desjardins and Roy. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nutrition Rodríguez-Daza, Maria Carolina Pulido-Mateos, Elena C. Lupien-Meilleur, Joseph Guyonnet, Denis Desjardins, Yves Roy, Denis Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further |
title | Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further |
title_full | Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further |
title_fullStr | Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further |
title_full_unstemmed | Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further |
title_short | Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further |
title_sort | polyphenol-mediated gut microbiota modulation: toward prebiotics and further |
topic | Nutrition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276758/ https://www.ncbi.nlm.nih.gov/pubmed/34268328 http://dx.doi.org/10.3389/fnut.2021.689456 |
work_keys_str_mv | AT rodriguezdazamariacarolina polyphenolmediatedgutmicrobiotamodulationtowardprebioticsandfurther AT pulidomateoselenac polyphenolmediatedgutmicrobiotamodulationtowardprebioticsandfurther AT lupienmeilleurjoseph polyphenolmediatedgutmicrobiotamodulationtowardprebioticsandfurther AT guyonnetdenis polyphenolmediatedgutmicrobiotamodulationtowardprebioticsandfurther AT desjardinsyves polyphenolmediatedgutmicrobiotamodulationtowardprebioticsandfurther AT roydenis polyphenolmediatedgutmicrobiotamodulationtowardprebioticsandfurther |